Covid-19 Drug interactions
The Liverpool Drug Interactions website team developed a freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for the treatment of COVID-19 and commonly prescribed co-medications.
Find out more here.
We’ve published a video explaining the work we have done in 2020 to bring you the COVID-19 Drug Interactions website.
— COVID-19 Drug Interactions (@covidDDIs) October 12, 2020
COVID-19: Dangerous drug combinations? https://t.co/yAvptS9952 via @YouTube
Other posts
AGILE trial reports on antiviral activity of molnupiravir in vaccinated and unvaccinated individuals infected with contemporaneous variants of SARS-CoV-2
The antiviral drug molnupiravir received regulatory approval for treating people with mild to moderate COVID-19…
Learning and confirming in publicly funded antiviral trials
Reporting the phase 2 results from the UK AGILE CST-2 study of molnupiravir for SARS-CoV-2…
First antiviral pill to treat Covid-19 approved in UK
A “game-changing” antiviral pill that is part of the AGILE Coronavirus Drug Testing Initiative has…
AGILE Covid-19 drug testing platform opens new trial in South Africa
A new international trial to assess whether high doses of the antiparasitic drug nitazoxanide could…
First patient dosed in latest stage of AGILE COVID-19 drug trial
